Abstract
Corona Virus Disease (COVID-19), a threat to global public health, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) has now spread to more than two hundred countries in the world. This ongoing pandemic has already been exhausted our health care systems. So determining or predicting the need of healthcare resources has now become a number one priority and the length of hospitalization is a scale which represents the function of the health system of countries. Our objectives were to see the length of hospital stay of COVID-19 patients and its relationship with liver function abnormalities. This obser- vational cross-sectional study was carried out in the COVID-19 inpatient department of BSMMU on 96 patients who are RT-PCR positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Liver function abnormalities (ALT, AST, ALP, PT, serum biliru- bin and serum albumin) were recorded precisely. Length of hospital stay was documented. Occurrence of liver function abnormalities and their relation with length of hospital stay were assessed statistically. Total 96 patients were included. Mean hospital stay was found to be 14.0±6.2 with range from 5.0 to 33 days. Total 49(51.0%) patients required hospital staying ≤14 days and 47(49%) patients were found hospital stay > 14 days. Mean length of hospital stay in case of mild COVID-19 patients was 6.76±1.12 days, in case of moderate Covid-19 patients was 12.22±1.91 days and in severe group it was 19.18±4.81 days. The mean length of hospital stay was statistically significant with raised ALT (18.9±6.2), raised AST(18.9±5.9) and low serum albumin (19.4±7.1) group (p<0.05). No significant association was found between mean length of hospital stay and raised ALP, PT and S. bilirubin group. This study showed that length of hospital stay were significantly higher among severe COVID-19 patients and among liver function abnormalities raised ALT, raised AST and low serum albumin were associated with significant longer hospital stay. Assessing the length of hospital stay is helpful in under- standing and predicting hospital bed demand and optimizing the use of healthcare resources.
 BSMMU J 2021; 14 (COVID -19 Supplement): 8-12
Highlights
Our objectives were to see the length of hospital stay of COVID-19 patients and its relationship with liver function abnormalities
This study showed that length of hospital stay were significantly higher among severe COVID-19 patients and among liver function abnormalities raised ALT, raised AST and low serum albumin were associated with significant longer hospital stay
A newly emerging infectious disease named Coronavirus disease 2019 (COVID-19) has become a global public health issue caused by severe acute respiratory syndrome corona virus (SARS-CoV-2)
Summary
A newly emerging infectious disease named Coronavirus disease 2019 (COVID-19) has become a global public health issue caused by severe acute respiratory syndrome corona virus (SARS-CoV-2) This ongoing pandemic which may develop to acute respiratory distress syndrome or multiple organ failure was first identified in December 2019 in Wuhan, Hubei, China.[1] According to current estimate up to 15-18% of patients may become severe or critically ill, less than 5% case become fatal, some of them require intensive care unit care.[2] Most commonly reported symptoms are respiratory tract manifestations in patients with COVID-19.3 Many case series have been reported variable involvement of GI and hepatic involvement apart from respiratory system involvement.[4] Significantly higher risk of liver function abnormalities seen in those with severe disease than in those with non severe disease. Among the deceased persons the incidence of liver injury might reach as high as 78%.5
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
